Will Gilead Sciences Remdesivir Help Arrest the Coronavirus?
Right now, GILD holds a strictly defensive spot among my holdings.
No Bottom Yet for Pfizer's Charts but We Have Price Targets to Watch
The daily trading volume has increased over the past two months telling us that PFE is not falling of its own weight but rather investors are voting with their feet.
3M Needs to Form a Lengthy Base Before It Is Attractive Again
The technology giant has been in bearish mode for quite some time and likely will need to rebase before the coast is clear to buy it.
Sangamo Therapeutics Shows Promise
Let's check out the charts of SGMO and come up with a trading strategy.
Global Blood Therapeutics Shows More Downside Risk Right Now
There may be more weakness ahead.
The Charts of Amarin Tell Us That a Close Below $14 Is Key
Let's check the charts of this bio pharmaceutical company that develops drugs for cardiovascular disease.
The Charts of Livongo Health Could Use More Development
LVGO went public in late July so we don't have a lot of price history.
Jim Cramer: Here Are 10 Stocks for a Stay-at-Home Pandemic
These companies should continue to work, while we wait for a cure or a vaccine or the darned virus to run its course.
Earnings, Coronavirus Fears Make Teladoc Health a Good Call
The charts of TDOC are very strong and capable of supporting further gains.
This Fall Is Unlike the Others
There are no prior examples when a sharp drop comes right after making new all-time highs while also extremely overbought.